Tvardi Therapeutics, Inc. (TVRD)
Data as of , from SEC Form 4 filings.
See up to 3 months of TVRD. The 7-day demo opens the 1M and 3M ranges and puts TVRD on your watchlist.
Start 7-day demoLatest TVRD insider trades
About Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. is an SEC registrant, filing under CIK 0001346830, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TVRD Form 4 activity by transaction type, last 90 days
No Form 4 activity for TVRD in the last 90 days.
TVRD insider transactions (Form 4)
1413 Form 4 filings on record, the earliest from Nov 6, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Susan Ph.D. Shiff | Grant or award | Stock Option (right to buy) | 6,000 | $0.00 | - | |
| Cynthia Smith | Grant or award | Stock Option (right to buy) | 6,000 | $0.00 | - | |
| Sujal Shah | Grant or award | Stock Option (right to buy) | 6,000 | $0.00 | - | |
| Wallace L. Hall Jr. | Grant or award | Stock Option (right to buy) | 6,000 | $0.00 | - | |
| Michael S. Wyzga | Grant or award | Stock Option (right to buy) | 6,000 | $0.00 | - | |
| Stephen Paul O'Brien - Officer | Grant or award | Employee Stock Option (right to buy) | 15,000 | $0.00 | - | |
| Avi Daniel Conn - Officer | Grant or award | Employee Stock Option (right to buy) | 45,000 | $0.00 | - | |
| John Saewook M.D. Kauh - Officer | Grant or award | Employee Stock Option (right to buy) | 45,000 | $0.00 | - | |
| Imran Nizamudin Alibhai - Officer | Grant or award | Employee Stock Option (right to buy) | 115,000 | $0.00 | - | |
 Samuel David Tweardy | Other | Common Stock | 315,658 | $0.00 | - | |
| Samuel David Tweardy | Other | Common Stock | 315,658 | $0.00 | - | |
| Michael S. Wyzga | Grant or award | Stock Option (right to buy) | 12,000 | $0.00 | - | |
| Michael S. Wyzga | Grant or award | Stock Option (right to buy) | 18,441 | - | - | |
| Christopher Posner - Officer | Open-market sale | Common Stock | 3,668 | $0.29 | $1K |
TVRD insider trading FAQ
What is the latest insider trade for TVRD?
Tvardi Therapeutics, Inc. (TVRD) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-11. The full record for TVRD runs to 13 Form 4 filings, the earliest from 2024-11-06. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TVRD stock?
No insider purchases of TVRD were filed in the last 90 days.
How many insiders are selling TVRD stock?
No insider sales of TVRD were filed in the last 90 days. 1 sale is on record for this company.
Where can I see TVRD SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TVRD Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Susan Ph.D. Shiff view on EDGAR
- - Cynthia Smith view on EDGAR
- - Sujal Shah view on EDGAR
- - Wallace L. Hall Jr. view on EDGAR
- - Michael S. Wyzga view on EDGAR
- - Stephen Paul O'Brien view on EDGAR
- - Avi Daniel Conn view on EDGAR
- - John Saewook M.D. Kauh view on EDGAR
- - Imran Nizamudin Alibhai view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TVRD's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TVRD with a 7-day demo
- TVRD on your watchlist
- Every TVRD Form 4 filing on record
- Up to 3 months of TVRD price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
